You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage II cutaneous T-cell non-Hodgkin lymphoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uterine Cervical Tumors Trial in Worldwide (Nintedanib, Placebo)

Active, not recruiting
  • Uterine Cervical Neoplasms
  • Bruxelles, Belgium
  • +31 more
Mar 1, 2022

Anesthesia, Local Trial in Minya (Intraligamental local anesthetic injection)

Completed
  • Anesthesia, Local
  • Intraligamental local anesthetic injection
  • Minya, Egypt
    Faculty of Dentistry, Minia University
May 26, 2023

Breast Cancer Patients

Recruiting
  • Breast Cancer
  • Blood sample
  • Pavia, Lombardia, Italy
    Istituti Clinici Scientifici Maugeri SpA
Sep 15, 2023

Lymphoma, Solid Tumor Trial in Rockledge (drug, procedure, other)

Completed
Has Results
  • Lymphoma
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Rockledge, Pennsylvania
    Fox Chase Cancer Center
Feb 2, 2021

NSCLC Stage IV Trial in Taipei (therapeutic thoracic surgery, Afatinib)

Recruiting
  • NSCLC Stage IV
  • Taipei, Taiwan
  • +1 more
Mar 8, 2022

COVID-19 Infection Trial (WPV01, Placebo)

Not yet recruiting
  • COVID-19 Infection
  • (no location specified)
Mar 1, 2023

Atrial Fibrillation, Hemostasis Trial in Overland Park, Independence, Kansas City (Vascular closure with LockeT device)

Recruiting
  • Atrial Fibrillation
  • Hemostasis
  • Vascular closure with LockeT device
  • Overland Park, Kansas
  • +5 more
Oct 3, 2023

AML, Adult Trial (Pharmacoscopy, Clinical standard-of-care (physician's choice))

Not yet recruiting
  • AML, Adult
  • Pharmacoscopy
  • Clinical standard-of-care (physician's choice)
  • (no location specified)
Nov 20, 2023

Osteoarthritis, Hip Trial in Halifax (BMAC/PRP Injection, Cortisone Injection)

Terminated
  • Osteoarthritis, Hip
  • BMAC/PRP Injection
  • Cortisone Injection
  • Halifax, Nova Scotia, Canada
    Nova Scotia Health Authority
Mar 7, 2022

Advanced Esophageal Squamous Cell Carcinoma Trial in Beijing, Xiamen, Xinxiang (Afatinib, Irinotecan)

Recruiting
  • Advanced Esophageal Squamous Cell Carcinoma
  • Beijing, China
  • +2 more
Apr 6, 2023

Class II Malocclusion Trial in Cairo (Mandibular Protraction Appliance, PowerScope Appliance)

Completed
  • Class II Malocclusion
  • Mandibular Protraction Appliance
  • PowerScope Appliance
  • Cairo, Egypt
    Abubakr Mohamed Fouad
Oct 12, 2022

Non-hodgkins Lymphoma Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

Terminated
  • Non-hodgkins Lymphoma
  • Antineoplaston therapy (Atengenal + Astugenal)
  • Houston, Texas
    Burzynski Clinic
Feb 1, 2018

Development of Multi-specific Antibodies Based on Immune

Not yet recruiting
  • Invasive Breast Cancer
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Mar 2, 2023

    Carcinoma, Non-small Cell Lung Trial in Changsha (ethaselen)

    Completed
    • Carcinoma, Non-small Cell Lung
    • Changsha, Hunan, China
      Hunan province tumor hospital
    Mar 1, 2022

    CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations

    Completed
    • Cystic Fibrosis
      • Denver, Colorado
        National Jewish Health
      Aug 31, 2021

      Triple-negative Breast Cancer Trial in Shanghai (A1: SHR-A1811, A2: SHR-A1811 with Camrelizumab, B1: TROP2 ADC)

      Not yet recruiting
      • Triple-negative Breast Cancer
      • A1: SHR-A1811
      • +11 more
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Feb 19, 2023

      Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Carrilizumab, bevacizumab,capecitabine
      • (no location specified)
      Jul 20, 2023

      Flapless Surgical Treatment of Peri-implantitis

      Completed
      • Peri-Implantitis
      • flapless surgery
      • Madrid, Spain
        Ana Carrillo de Albornoz
      Oct 16, 2023

      Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ

      Recruiting
      • Hypertension,Essential
        • Seoul, Korea, Republic of
          Seoul National University Bundang Hospital
        Jul 7, 2022

        MDS, AML Trial in Bronx (Venetoclax, Decitabine)

        Recruiting
        • MDS
        • AML
        • Bronx, New York
          Montefiore Medical Center
        Jul 22, 2022

        Triple Negative Breast Cancer Trial in Madison (Akt/ERK Inhibitor ONC201, Methionine-Restricted Diet)

        Terminated
        Has Results
        • Triple Negative Breast Cancer
        • Akt/ERK Inhibitor ONC201
        • Methionine-Restricted Diet
        • Madison, Wisconsin
          University of Wisconsin Carbone Cancer Center
        Feb 11, 2022

        Squamous Cell Carcinoma of the Oropharynx Trial in United States (Radiation Therapy)

        Not yet recruiting
        • Squamous Cell Carcinoma of the Oropharynx
        • Radiation Therapy
        • Miami, Florida
        • +3 more
        Jul 22, 2023

        Acute Myeloid Leukemia, Myeloproliferative Syndrome Trial in France (CPX-351)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Myeloproliferative Syndrome
        • Amiens, France
        • +33 more
        Feb 7, 2022

        Tissue Specimens From Solid Tumors or Blood Disorders and Their

        Recruiting
        • Neoplasms
        • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 21, 2023

          Pancreatic Cancer Trial in Hangzhou (Canagliflozin and Gemcitabine, Gemcitabine)

          Not yet recruiting
          • Pancreatic Cancer
          • Hangzhou, Zhejiang, China
            Hangzhou first people's Hospital
          Jun 11, 2023